Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Feb 28;16(8):921-6.
doi: 10.3748/wjg.v16.i8.921.

Folate and fiber in the prevention of colorectal cancer: between shadows and the light

Review

Folate and fiber in the prevention of colorectal cancer: between shadows and the light

Wan Du et al. World J Gastroenterol. .

Abstract

Colorectal cancer (CRC) is one of the most common malignancies and causes of cancer deaths throughout the world. Endoscopy has its functional and financial limitations; therefore, chemoprevention might be crucial in reducing the incidence of CRC. Although a number of studies have demonstrated the potential chemopreventive effects of folate (or folic acid), many challenges still remain. The relationship between folate intake and CRC risk is a complex association that might depend on many factors including gender, age, alcohol consumption, and smoking, all of which interfere with folate metabolism. The supplementary dose of fiber, the length of time required to observe the effects, and confounding factors exposed during the trial might also influence these findings. Therefore, more evidence from clinical studies is needed regarding the mechanisms that underlie the actions of bioactive food components in minimizing the risk of CRC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Folate supplementation protection against colorectal cancer (CRC) might depend on the stage of colorectal carcinogenesis and might be influenced by many factors.

Similar articles

Cited by

References

    1. Acheson AG, Scholefield JH. Survival from cancers of the colon and rectum in England and Wales up to 2001. Br J Cancer. 2008;99 Suppl 1:S33–S34. - PMC - PubMed
    1. Ferro SA, Myer BS, Wolff DA, Poniewierski MS, Culakova E, Cosler LE, Scarpace SL, Khorana AA, Lyman GH. Variation in the cost of medications for the treatment of colorectal cancer. Am J Manag Care. 2008;14:717–725. - PubMed
    1. Tsoi KK, Ng SS, Leung MC, Sung JJ. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia. Aliment Pharmacol Ther. 2008;28:353–363. - PubMed
    1. Milner JA. Molecular targets for bioactive food components. J Nutr. 2004;134:2492S–2498S. - PubMed
    1. Stan SD, Kar S, Stoner GD, Singh SV. Bioactive food components and cancer risk reduction. J Cell Biochem. 2008;104:339–356. - PubMed

MeSH terms